Formulation and development of paediatric orally disintegrating carbamazepine tablets.

Canadell-Heredia, R; Suñé-Pou, M; Nardi-Ricart, A; Pérez-Lozano, P; Suñé-Negre, J M; García-Montoya, E.

Afiliação

Canadell-Heredia R; Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
Suñé-Pou M; Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
Nardi-Ricart A; Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology research group. Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l'Hospitalet, 199-203, 08090 L'Hospitalet de Llobregat, Spain.
Pérez-Lozano P; Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
Suñé-Negre JM; Department of Pharmacy and Pharmaceutical Technology and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Spain.
García-Montoya E; Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology research group. Bellvitge Biomedical Research Institute (IDIBELL), Av. Granvia de l'Hospitalet, 199-203, 08090 L'Hospitalet de Llobregat, Spain.

Saudi Pharm J ; 30(11): 1612-1622, 2022 Nov.

Article em En | MEDLINE | ID: mdl-36465846